学科与关键词
关键词
Diffuse large B-cell lymphomacentral nervous system relapselenalidomide
- The Prognostic Value of Dynamic Change of NK-Cell Counts in Diffuse Large B-Cell Lymphoma Treated with R-CHOPHuan, Chen; Zheng, Zhongxin; Wei, Yongqiang; Guo, Xutao; Wei, Qi; Feng, Ru; Wei, Xiaolei65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Glofitamab Monotherapy Demonstrates High Complete Response Rates and Manageable Safety in Chinese Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and ≥ 2 Prior TherapiesSong, Yu-Qin; Zhang, Hui-Lai; Huang, Hui-Qiang; Zhang, Qing-Yuan; Jing, Hong-Mei; Wang, Chao; Wu, Chun; Li, Dong-Hang; Dai, Yu; Humphrey, Kathryn; Zhu, Jun64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.被引 1
- Phase 2 Search Study:XPO1 Inhibitor (ATG-010) Monotherapy in Heavily Pretreated Chinese Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaSong, Yuqin; Cai, Qingqing; Zhang, Qingyuan; Sun, Xiuhua; Yang, Haiyan; Yao, Zhihua; Zou, Liqun; Zhang, Liling; Cao, Junning; Wang, Tingyu; Li, Lanfang; Liu, Yao; Jing, Hongmei; Gao, Sujun; Ding, Kaiyang; Liu, Bingshan; Zhao, Jun; Zhu, Jun65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
